Uncategorized Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Given Consensus Recommendation of “Moderate Buy” by Brokerages otakuyassine3@gmail.com Jan 5, 2025 Shares of Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Get Free Report) have been assigned a consensus...
Uncategorized Research Analysts’ Weekly Ratings Changes for Sangamo Therapeutics (SGMO) otakuyassine3@gmail.com Dec 18, 2024 A number of firms have modified their ratings and price targets on shares of Sangamo...